Published completely in #JACCIMG ! If you haven’t read it yet: time to do it 😁 Precision phenotyping for improved disease understanding and outcomes prediction in primary mitral regurgitation!
New issue of #JACCIMG is out!
Novel data-driven phenogrouping & explainable #AI exploring 400 prospective patients aided in #echofirst data integration to identify improved event-free survival following MV surgery for primary #vhdMR. https://t.co/mnEqu3VRuZ #MachineLearning
Félicitations à Philippe Pibarot qui reçoit le Prix Fondation - Carrière en recherche - Pour ses avancées majeures en recherche sur les maladies valvulaires cardiaques et ses innovations technologiques.
🚨Our last publication. Emerging biomarker, Human Epididymis Protein 4 in Transcatheter Aortic Valve Implantation: Diagnostic and Prognostic Value | JACC: Advances https://t.co/OoqFda0U9b
Great job!
Finally some improvement in current scholarships support for grad students in Canada! Proud to have contributed in a way to this large campaign in the previous years!
I salute @SupportOurSci hard work in getting this done, @FP_Champagne and @Canada Gov for these investments.
#Budget2024 💰 makes the largest investment in 20+ years for grad students & postdocs! It will support financial needs, boost mental well-being, allow focus on research, & promote diversity by easing barriers for underrepresented groups. 🎉💪🏽#SOSBudget2024
Proud to present our AR multicenter project at the ACC congress. I’m grateful to my mentors, @NAjmoneMarsan and J.J.Bax, to my LUMC team @FedericoFortuni and to @PPibarot and @B26Jeremy and the rest of the centers without whose collaboration this wouldn’t have been possible.
#ValveDiseaseDay in #Quebec City
🙏 to the wonderful event partners who hosted 200 participants! @IUCPQ@PPibarot
A stethoscope check 🩺can be the first step in the detection of #heartvalvedisease. It’s common, serious, but treatable.
Learn more at https://t.co/7n1OV5UEWV
Today is Heart Valve Disease Awareness Day. We are organizing 'Listen to your heart' campaigns across Canada including one here in Québec city. Since this morning we have constant line-up of >50 people! @HeartValveVoice@SCC_CCS@IUCPQ@FondationIUCPQ
https://t.co/xqoNsokDeW
Tomorrow, Feb 22nd is @valvediseaseday and we are proud to partner with @Aging_Research & @SCC_CCS
to raise awareness of #heartvalvedisease which affects over 1 million Canadians.
Learn more about what’s happening across Canada at ➡️ https://t.co/aG5dzc195I
This expert review discusses the utilization of TEER in inoperable and high-risk patients beyond recognized indications, examining outcomes and limitations in diverse populations who are not normally included in major trials (e.g., post-myocardial infarction mitral regurgitation, hypertrophic obstructive cardiomyopathy, recurrent mitral regurgitation after surgical intervention).
https://t.co/sQKyN1k8nr
In this state-of-the-art review from the #PCRLV 2023 issue, the Authors propose an overview on transcatheter mitral valve replacement (TMVR) for the treatment of native mitral valve disease, from indication to results, with a glimpse into the future.
https://t.co/XdsOKV8Ezc
Very proud to be this year again in the list of the top 1% highly cited researchers in the field of Clinical Medicine. Special thanks to my fantastic research lab team and students @IUCPQ and to all my collaborators including @ClavelLabo@hahn_rt@JoaoLCavalcante@Clarivate
Honoured to have received the @scc_ccs Sex and Gender-Based Analysis Trainee Abstract Award in Clinical Sciences during the #VASC23 congress in Montréal ! Proud to have contributed in some extent to this field of study! A warm thanks to my mentors @ClavelLabo and @PPibarot@IUCPQ